Arrowhead Pharmaceuticals, Inc. (ARWR)
USD 9.74
(-8.8%)
USD 9.74
(-8.8%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 240.73 Million USD | -1.96% |
| 2022 | 232.81 Million USD | 68.35% |
| 2021 | 138.28 Million USD | 57.16% |
| 2020 | 87.99 Million USD | -47.87% |
| 2019 | 168.79 Million USD | 945.67% |
| 2018 | 16.14 Million USD | -48.6% |
| 2017 | 31.4 Million USD | 19736.49% |
| 2016 | 158.33 Thousand USD | -58.55% |
| 2015 | 382 Thousand USD | 118.29% |
| 2014 | 175 Thousand USD | -39.71% |
| 2013 | 290.26 Thousand USD | 97.63% |
| 2012 | 146.87 Thousand USD | -50.4% |
| 2011 | 296.13 Thousand USD | -52.24% |
| 2010 | 620.09 Thousand USD | -83.57% |
| 2009 | 3.77 Million USD | 189.53% |
| 2008 | 1.3 Million USD | 169.29% |
| 2007 | 483.93 Thousand USD | -18.73% |
| 2006 | 595.45 Thousand USD | 0.81% |
| 2005 | 590.68 Thousand USD | 200.9% |
| 2004 | 196.3 Thousand USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 2179.00 USD | -27.73% |
| 2001 | 3015.00 USD | -86.77% |
| 2000 | 22.78 Thousand USD | -33.27% |
| 1999 | 34.14 Thousand USD | 28.4% |
| 1998 | 26.59 Thousand USD | -32.88% |
| 1997 | 39.61 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | -4.78 Million USD | -5.68% |
| 2024 Q1 | -712 Thousand USD | -105.82% |
| 2024 Q2 | -4.52 Million USD | -535.53% |
| 2023 Q1 | 59.85 Million USD | 107.01% |
| 2023 Q4 | 12.23 Million USD | -2.49% |
| 2023 Q2 | 143.59 Million USD | 139.9% |
| 2023 Q3 | 12.55 Million USD | -91.26% |
| 2023 FY | 228.24 Million USD | -1.96% |
| 2022 Q3 | 29.8 Million USD | -80.02% |
| 2022 Q4 | 28.91 Million USD | -3.0% |
| 2022 Q1 | 24.86 Million USD | -35.05% |
| 2022 Q2 | 149.22 Million USD | 500.1% |
| 2022 FY | 232.81 Million USD | 68.35% |
| 2021 Q4 | 38.28 Million USD | -16.58% |
| 2021 Q1 | 21.3 Million USD | 179.1% |
| 2021 FY | 138.28 Million USD | 57.16% |
| 2021 Q2 | 32.81 Million USD | 54.02% |
| 2021 Q3 | 45.89 Million USD | 39.86% |
| 2020 Q1 | 29.45 Million USD | -31.96% |
| 2020 Q3 | 27.37 Million USD | 16.35% |
| 2020 FY | 87.99 Million USD | -47.87% |
| 2020 Q4 | 7.63 Million USD | -72.12% |
| 2020 Q2 | 23.52 Million USD | -20.12% |
| 2019 Q1 | 34.65 Million USD | 207.93% |
| 2019 Q3 | 42.69 Million USD | -11.32% |
| 2019 FY | 168.79 Million USD | 945.67% |
| 2019 Q2 | 48.14 Million USD | 38.92% |
| 2019 Q4 | 43.29 Million USD | 1.4% |
| 2018 Q1 | 3.5 Million USD | -59.72% |
| 2018 FY | 16.14 Million USD | -48.6% |
| 2018 Q3 | 727.37 Thousand USD | 11.88% |
| 2018 Q4 | 11.25 Million USD | 1447.34% |
| 2018 Q2 | 650.12 Thousand USD | -81.48% |
| 2017 Q3 | 9.34 Million USD | 3.97% |
| 2017 Q1 | 4.36 Million USD | 13869.59% |
| 2017 FY | 31.4 Million USD | 19736.49% |
| 2017 Q4 | 8.71 Million USD | -6.73% |
| 2017 Q2 | 8.98 Million USD | 105.84% |
| 2016 Q2 | 43.75 Thousand USD | 0.0% |
| 2016 Q4 | 31.25 Thousand USD | -21.05% |
| 2016 Q1 | 43.75 Thousand USD | 0.0% |
| 2016 FY | 158.33 Thousand USD | -58.55% |
| 2016 Q3 | 39.58 Thousand USD | -9.52% |
| 2015 Q2 | 43.75 Thousand USD | -74.38% |
| 2015 FY | 382 Thousand USD | 118.29% |
| 2015 Q1 | 170.75 Thousand USD | 290.29% |
| 2015 Q3 | 123.75 Thousand USD | 182.86% |
| 2015 Q4 | 43.75 Thousand USD | -64.65% |
| 2014 Q1 | 43.75 Thousand USD | 0.0% |
| 2014 Q3 | 43.75 Thousand USD | 0.0% |
| 2014 Q4 | 43.75 Thousand USD | 0.0% |
| 2014 FY | 175 Thousand USD | -39.71% |
| 2014 Q2 | 43.75 Thousand USD | 0.0% |
| 2013 Q1 | 159.01 Thousand USD | 263.47% |
| 2013 Q2 | 43.75 Thousand USD | -72.49% |
| 2013 Q3 | 43.75 Thousand USD | 0.0% |
| 2013 Q4 | 43.75 Thousand USD | 0.0% |
| 2013 FY | 290.26 Thousand USD | 97.63% |
| 2012 FY | 146.87 Thousand USD | -50.4% |
| 2012 Q3 | 47.91 Thousand USD | 53.33% |
| 2012 Q1 | -71.59 Million USD | -124.62% |
| 2012 Q2 | 31.25 Thousand USD | 100.04% |
| 2012 Q4 | 43.75 Thousand USD | -8.7% |
| 2011 FY | 296.13 Thousand USD | -52.24% |
| 2011 Q4 | 290.84 Million USD | 0.0% |
| 2011 Q3 | - USD | -100.0% |
| 2011 Q2 | 296.13 Thousand USD | -94.07% |
| 2011 Q1 | 4.99 Million USD | 2664.32% |
| 2010 Q4 | 180.69 Thousand USD | 34.86% |
| 2010 FY | 620.09 Thousand USD | -83.57% |
| 2010 Q3 | 133.99 Thousand USD | -14.84% |
| 2010 Q2 | 157.34 Thousand USD | 6.27% |
| 2010 Q1 | 148.06 Thousand USD | -26.91% |
| 2009 Q4 | 202.58 Thousand USD | -92.31% |
| 2009 FY | 3.77 Million USD | 189.53% |
| 2009 Q1 | 701.72 Thousand USD | 174.45% |
| 2009 Q2 | 235.65 Thousand USD | -66.42% |
| 2009 Q3 | 2.63 Million USD | 1017.42% |
| 2008 FY | 1.3 Million USD | 169.29% |
| 2008 Q4 | -942.56 Thousand USD | -1362.98% |
| 2008 Q3 | 74.63 Thousand USD | -77.72% |
| 2008 Q1 | 75.65 Thousand USD | -62.46% |
| 2008 Q2 | 334.94 Thousand USD | 342.73% |
| 2007 FY | 483.93 Thousand USD | -18.73% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q1 | 11.09 Thousand USD | -71.72% |
| 2007 Q3 | 274.99 Thousand USD | 0.0% |
| 2007 Q4 | 201.54 Thousand USD | -26.71% |
| 2006 FY | 595.45 Thousand USD | 0.81% |
| 2006 Q1 | 252.5 Thousand USD | 20.08% |
| 2006 Q2 | 57.5 Thousand USD | -77.23% |
| 2006 Q3 | 246.22 Thousand USD | 328.22% |
| 2006 Q4 | 39.22 Thousand USD | -84.07% |
| 2005 Q3 | 173.3 Thousand USD | 123.29% |
| 2005 Q4 | 210.27 Thousand USD | 21.33% |
| 2005 Q1 | 129.49 Thousand USD | -18.61% |
| 2005 Q2 | 77.61 Thousand USD | -40.06% |
| 2005 FY | 590.68 Thousand USD | 200.9% |
| 2004 Q4 | 159.1 Thousand USD | 327.7% |
| 2004 Q3 | 37.2 Thousand USD | 0.0% |
| 2004 Q1 | - USD | 100.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | 196.3 Thousand USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q4 | -2732.00 USD | -1479.8% |
| 2003 Q3 | 198.00 USD | -76.81% |
| 2003 Q2 | 854.00 USD | -43.74% |
| 2003 Q1 | 1518.00 USD | 1665.12% |
| 2002 Q4 | 86.00 USD | -67.05% |
| 2002 FY | 2179.00 USD | -27.73% |
| 2002 Q1 | 1292.00 USD | 124.65% |
| 2002 Q2 | 540.00 USD | -58.2% |
| 2002 Q3 | 261.00 USD | -51.67% |
| 2001 Q3 | 3147.00 USD | 3435.96% |
| 2001 FY | 3015.00 USD | -86.77% |
| 2001 Q2 | 89.00 USD | -98.23% |
| 2001 Q1 | 5020.00 USD | -28.92% |
| 2001 Q4 | -5241.00 USD | -266.54% |
| 2000 Q2 | 6354.00 USD | 33.74% |
| 2000 Q1 | 4751.00 USD | -76.25% |
| 2000 FY | 22.78 Thousand USD | -33.27% |
| 2000 Q3 | 4617.00 USD | -27.34% |
| 2000 Q4 | 7062.00 USD | 52.96% |
| 1999 FY | 34.14 Thousand USD | 28.4% |
| 1999 Q2 | 10 Thousand USD | 0.0% |
| 1999 Q4 | 20 Thousand USD | 100.0% |
| 1999 Q3 | 10 Thousand USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | -100.0% |
| 1998 FY | 26.59 Thousand USD | -32.88% |
| 1998 Q2 | 10 Thousand USD | 0.0% |
| 1997 FY | 39.61 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -533.097% |
| Alkermes plc | 1.37 Billion USD | 82.488% |
| Agenus Inc. | 139.61 Million USD | -72.428% |
| Aptorum Group Limited | -1.11 Million USD | 21696.626% |
| Ardelyx, Inc. | 106.66 Million USD | -125.701% |
| Dyadic International, Inc. | 922.95 Thousand USD | -25983.014% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1043.037% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 137786.381% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1902.199% |
| Novavax, Inc. | 639.93 Million USD | 62.381% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 613.963% |
| Pyxis Oncology, Inc. | -2 Million USD | 12136.75% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 46686.718% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1164.165% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 544897.23% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 45780.266% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 345.105% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -29916.833% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 293679.268% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -77.968% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2958.506% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 348.308% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 84.14% |
| AlloVir, Inc. | -398 Thousand USD | 60586.181% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -56677.123% |
| Bicycle Therapeutics plc | -129.52 Million USD | 285.867% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -200512.5% |
| ChromaDex Corporation | 50.78 Million USD | -374.074% |
| Chimerix, Inc. | 324 Thousand USD | -74200.926% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 872.387% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 410.234% |
| CRISPR Therapeutics AG | 240.95 Million USD | 0.092% |
| Precision BioSciences, Inc. | 40.47 Million USD | -494.819% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 345.24% |
| Fortress Biotech, Inc. | 57.85 Million USD | -316.115% |
| Fortress Biotech, Inc. | 57.85 Million USD | -316.115% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1352.223% |
| ImmuCell Corporation | 4.39 Million USD | -5375.875% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 326.845% |
| Immix Biopharma, Inc. | -5468.00 USD | 4402715.216% |
| Incyte Corporation | 3.44 Billion USD | 93.003% |
| Innoviva, Inc. | 261.06 Million USD | 7.787% |
| IO Biotech, Inc. | -756 Thousand USD | 31943.254% |
| Jaguar Health, Inc. | 7.72 Million USD | -3016.714% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 36355.271% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -101.026% |
| ContextLogic Inc. | 59 Million USD | -308.025% |
| MiMedx Group, Inc. | 266.84 Million USD | 9.784% |
| MEI Pharma, Inc. | 49.32 Million USD | -388.039% |
| NextCure, Inc. | -3.68 Million USD | 6634.609% |
| Onconetix, Inc. | -1.12 Million USD | 21457.565% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 931.038% |
| Opthea Limited | 21.72 Thousand USD | -1108256.354% |
| Psyence Biomedical Ltd. | -240.00 USD | 100306350.0% |
| Vaxcyte, Inc. | -75 Million USD | 420.98% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 420040.341% |
| Precigen, Inc. | 106 Thousand USD | -227008.491% |
| Pharming Group N.V. | 220.1 Million USD | -9.373% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -46644.66% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -23758.771% |
| PureTech Health plc | -1.6 Million USD | 15117.779% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -119.305% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 232.704% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 631.131% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1194.897% |
| Acelyrin, Inc. | -115 Thousand USD | 209434.783% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2395234.812% |
| Summit Therapeutics Inc. | -2.05 Million USD | 11843.171% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 42260.245% |
| Senti Biosciences, Inc. | -2.68 Million USD | 9072.605% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5842.607% |
| Elevation Oncology, Inc. | -39 Thousand USD | 617369.231% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 5117.403% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 6206.851% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -726.444% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -48435.282% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 437800.0% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -131.256% |
| Seer, Inc. | 7.02 Million USD | -3325.857% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -5398.744% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1017.359% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 203267.329% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 168092.547% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -39429.557% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -99.823% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 23.253% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4814800.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -9252.564% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 474548.167% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -719.189% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 103865.086% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 49029.878% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3491.589% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 50829.646% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2314859.615% |
| Soligenix, Inc. | 97.31 Thousand USD | -247287.243% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2327.172% |
| Kura Oncology, Inc. | -849 Thousand USD | 28455.124% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 458.749% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 163865.306% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -143.071% |
| Autolus Therapeutics plc | -4.86 Million USD | 5046.271% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -481.682% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 143394.643% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -154.146% |
| GRI Bio, Inc. | 10.84 Million USD | -2120.598% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -9377.808% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2871.21% |
| IGM Biosciences, Inc. | -211.66 Million USD | 213.737% |
| INmune Bio, Inc. | 155 Thousand USD | -155212.903% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -288.665% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16081.972% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37224.453% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 822450.892% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -59784.328% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 12160.872% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 77012.141% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -154.851% |
| Verastem, Inc. | -62 Thousand USD | 388382.258% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -9786.448% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 92335.632% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -7852.924% |
| Histogen Inc. | 3.76 Million USD | -6287.238% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -41681.287% |
| Surrozen, Inc. | -27.23 Million USD | 984.08% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4567.155% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 20079.998% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1038.648% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1100.554% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 12158433.333% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3868.319% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 358704.817% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -55.523% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -165013.169% |
| Apollomics, Inc. | 127 Thousand USD | -189455.118% |
| Amarin Corporation plc | 165.54 Million USD | -45.423% |
| Mesoblast Limited | -9.81 Million USD | 2552.725% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1358.47% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 317.881% |
| Synaptogenix, Inc. | -6347.00 USD | 3792994.281% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 472129.412% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -49.187% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 86.304% |
| Better Therapeutics, Inc. | -2.72 Million USD | 8921.363% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 314.633% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 28.794% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2110329.663% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 3945.607% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21826.986% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -3189.628% |
| Insmed Incorporated | 239.63 Million USD | -0.459% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -6628.2% |
| OmniAb, Inc. | 14.66 Million USD | -1541.338% |
| Alector, Inc. | -95.05 Million USD | 353.264% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -91.636% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 653.885% |
| Zai Lab Limited | 170.9 Million USD | -40.861% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -194.02% |
| Aura Biosciences, Inc. | -1.29 Million USD | 18689.575% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -185080.769% |
| Immunic, Inc. | -111 Thousand USD | 216978.378% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1418.45% |
| Veracyte, Inc. | 248.14 Million USD | 2.987% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.444% |
| FibroGen, Inc. | 128.9 Million USD | -86.755% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 42683610.638% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2163.404% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 92.917% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -61785.604% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 32.253% |
| TG Therapeutics, Inc. | 219.1 Million USD | -9.87% |
| Galecto, Inc. | -830 Thousand USD | 29104.217% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 17481.588% |
| Fortrea Holdings Inc. | 424 Million USD | 43.223% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 379.382% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 42557.672% |
| XBiotech Inc. | -1.74 Million USD | 13903.612% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 21826.986% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 618.033% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 418.711% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -227.963% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1332.691% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 38.121% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 584.893% |
| Vaxxinity, Inc. | -2.23 Million USD | 10875.962% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 26.325% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2225.913% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -884.561% |
| NexImmune, Inc. | -1.02 Million USD | 23586.983% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4457955.556% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3487.935% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.87% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 360336.132% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6879.358% |
| Ainos, Inc. | -253.73 Thousand USD | 94977.292% |
| Pluri Inc. | 322 Thousand USD | -74662.422% |
| Prothena Corporation plc | -129.2 Million USD | 286.326% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -377.422% |
| Celularity Inc. | 6.75 Million USD | -3463.805% |
| Rallybio Corporation | -150 Thousand USD | 160590.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 838.292% |
| MeiraGTx Holdings plc | 287 Thousand USD | -83779.791% |
| Omeros Corporation | -69.77 Million USD | 444.996% |
| Humacyte, Inc. | -76.55 Million USD | 414.481% |
| Immunocore Holdings plc | 248.39 Million USD | 3.082% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1687.02% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -285.905% |
| Blueprint Medicines Corporation | 236.58 Million USD | -1.755% |
| CalciMedica, Inc. | -58 Thousand USD | 415160.345% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 16981.837% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -728.549% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 8564.662% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 879.961% |
| Pulmatrix, Inc. | -8.22 Million USD | 3028.65% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 20675.641% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 60434.586% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 160.366% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -8573.307% |
| Cytokinetics, Incorporated | -322.59 Million USD | 174.625% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -27824.093% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 70696.774% |
| Vor Biopharma Inc. | -3.49 Million USD | 6993.9% |
| Roivant Sciences Ltd. | 109.23 Million USD | -120.383% |
| Evogene Ltd. | 1.39 Million USD | -17107.648% |
| ProKidney Corp. | -3.16 Million USD | 7696.56% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 648.221% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3410.792% |
| CorMedix Inc. | -205.56 Thousand USD | 117210.653% |
| BioLineRx Ltd. | 1.1 Million USD | -21626.986% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 406.002% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 729600.0% |
| Atai Life Sciences N.V. | -5000.00 USD | 4814800.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 197652.089% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 250865.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 17431.533% |
| Sagimet Biosciences Inc. | 2 Million USD | -11936.75% |
| MediciNova, Inc. | 979.7 Thousand USD | -24472.193% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 385.505% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 254697.853% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1261.806% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 1.554% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5830.421% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 72.403% |
| Mereo BioPharma Group plc | 7.42 Million USD | -3141.786% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 77756.452% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2006225.0% |
| Absci Corporation | -41.84 Million USD | 675.247% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4814800.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 415.21% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 9881.999% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -12.632% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 25682.891% |
| Allakos Inc. | -6.14 Million USD | 4020.127% |
| Imunon, Inc. | -720 Thousand USD | 33535.184% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 448.912% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 49.414% |
| BioAtla, Inc. | -103.73 Million USD | 332.076% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2110329.663% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 135344.382% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 199.142% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 77506.752% |
| XOMA Corporation | 3.86 Million USD | -6135.043% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 443.49% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1527.248% |
| aTyr Pharma, Inc. | -2.38 Million USD | 10181.03% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1832.063% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 830220.69% |
| Viridian Therapeutics, Inc. | -1 Million USD | 23982.44% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1851807592.308% |
| Akari Therapeutics, Plc | -4000.00 USD | 6018475.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 62.202% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -123538.988% |
| UroGen Pharma Ltd. | 73.35 Million USD | -228.191% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1001.832% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2073414.212% |
| Orgenesis Inc. | -5.72 Million USD | 4304.978% |
| Entera Bio Ltd. | -56 Thousand USD | 429983.929% |
| GH Research PLC | -315 Thousand USD | 76523.81% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 127473.016% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 45954.286% |
| Xencor, Inc. | -85.26 Million USD | 382.354% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 109041.202% |
| Replimune Group, Inc. | -2.65 Million USD | 9167.232% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 24143.782% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -35.363% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -123538.988% |
| Portage Biotech Inc. | -54 Thousand USD | 445905.556% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 254697.853% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 63955.438% |
| OncoCyte Corporation | 413 Thousand USD | -58189.346% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 5355717.353% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 108439289.189% |
| Purple Biotech Ltd. | -196 Thousand USD | 122923.98% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2584.378% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2361.0% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2404.796% |
| HilleVax, Inc. | -2.15 Million USD | 11265.816% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 248280.412% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1604572.141% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 36138.174% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1046773.913% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 3207265.848% |
| Savara Inc. | -44.26 Million USD | 643.886% |
| Curis, Inc. | 9.81 Million USD | -2353.725% |
| Daré Bioscience, Inc. | 2.76 Million USD | -8592.294% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 193015.184% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 14023.366% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 105685.526% |
| BeiGene, Ltd. | 2.07 Billion USD | 88.42% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 8710.286% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 160.234% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -324.667% |
| Erasca, Inc. | -3.73 Million USD | 6550.563% |
| bluebird bio, Inc. | -4.03 Million USD | 6073.573% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 853225.664% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 87.359% |
| DBV Technologies S.A. | 15.72 Million USD | -1430.614% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 853225.664% |
| Moderna, Inc. | 2.15 Billion USD | 88.829% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 26409.836% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2906.932% |
| Molecular Templates, Inc. | 50.39 Million USD | -377.696% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 45013.246% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -79.938% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3969.094% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 711.888% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 316.629% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6809.448% |
| MacroGenics, Inc. | 50.52 Million USD | -376.448% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 4047.77% |
| Prime Medicine, Inc. | -147.9 Million USD | 262.763% |
| Aditxt, Inc. | -111.66 Thousand USD | 215696.454% |
| Adagene Inc. | 18.11 Million USD | -1229.184% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -49230.943% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -71.706% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -52.522% |
| SciSparc Ltd. | 2.19 Million USD | -10862.432% |
| Vericel Corporation | 135.57 Million USD | -77.565% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 961156.33% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 777115.687% |
| Generation Bio Co. | -73.91 Million USD | 425.709% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 55188.101% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -340.753% |
| Invivyd, Inc. | -2.02 Million USD | 11970.562% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 180.021% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 232833.618% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -149.808% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -144.928% |
| ADMA Biologics, Inc. | 88.21 Million USD | -172.886% |
| Clene Inc. | 533 Thousand USD | -45066.041% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -898.52% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 25255.172% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1261.806% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -12009.406% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 123988.409% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -383.355% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3494.459% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 28896.053% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -188.599% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -329168.793% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -352.833% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 239.002% |
| Trevena, Inc. | 1.45 Million USD | -16445.361% |
| Surrozen, Inc. | -27.23 Million USD | 984.08% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 68296.884% |
| Cingulate Inc. | -582.91 Thousand USD | 41398.262% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 776664.516% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1322.067% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 3180218.89% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 27425.199% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 64.635% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 24465.891% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 427374.502% |
| Kronos Bio, Inc. | 1.37 Million USD | -17446.283% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 548.58% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 82543.493% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 49399.221% |
| ImmunityBio, Inc. | -17.89 Million USD | 1445.64% |
| Korro Bio, Inc. | -3.63 Million USD | 6731.818% |
| Kineta, Inc. | 5.43 Million USD | -4330.977% |
| BioVie Inc. | -229.37 Thousand USD | 105051.673% |
| Codexis, Inc. | 57.33 Million USD | -319.882% |
| Celularity Inc. | 6.75 Million USD | -3463.805% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5898.879% |
| Celcuity Inc. | -142.77 Thousand USD | 168714.995% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -475754.912% |
| Cibus, Inc. | 1.42 Million USD | -16829.325% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 64467.647% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1150.373% |
| IN8bio, Inc. | -2.5 Million USD | 9725.55% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1027.795% |
| Annexon, Inc. | -3.26 Million USD | 7468.687% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 11877.642% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 676.79% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -37514.844% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 69.078% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -39.189% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 12770.263% |
| Arcellx, Inc. | 108.27 Million USD | -122.328% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 843.721% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -203.943% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1238.119% |
| Moolec Science SA | -143.3 Thousand USD | 168087.858% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 668.871% |
| Geron Corporation | -123.5 Million USD | 294.922% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -7223.852% |
| Royalty Pharma plc | 1.79 Billion USD | 86.58% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 443.466% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6664967.11% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -103938.186% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 316.072% |
| Humacyte, Inc. | -76.55 Million USD | 414.481% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 25462.578% |
| 89bio, Inc. | -273 Thousand USD | 88281.319% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 19251.551% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 28488.561% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 195819.512% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -21413.405% |
| Notable Labs, Ltd. | 113 Thousand USD | -212939.823% |
| Liquidia Corporation | 14.6 Million USD | -1548.87% |
| Mustang Bio, Inc. | -2.22 Million USD | 10919.551% |
| Immunovant, Inc. | -231 Thousand USD | 104314.286% |
| Quantum-Si incorporated | 488 Thousand USD | -49230.943% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 533.296% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 802550.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -12828.84% |
| Acasti Pharma Inc. | -11 Thousand USD | 2188600.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 117751.515% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 37224.453% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 243.712% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -21117.984% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 63285.039% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 12394.944% |
| PepGen Inc. | -1.18 Million USD | 20432.348% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 189655.118% |
| United Therapeutics Corporation | 2.07 Billion USD | 88.37% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1151.382% |
| Solid Biosciences Inc. | -76.56 Million USD | 414.427% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 291606.727% |
| Immuneering Corporation | -764.13 Thousand USD | 31604.126% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -363196.813% |
| Belite Bio, Inc | -399 Thousand USD | 60434.586% |
| XOMA Corporation | 3.86 Million USD | -6135.043% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1301.512% |
| Bionomics Limited | -434.44 Thousand USD | 55511.567% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22514.804% |
| uniQure N.V. | 2.21 Million USD | -10768.397% |
| Cassava Sciences, Inc. | -89.42 Million USD | 369.209% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 361.472% |
| Forte Biosciences, Inc. | -9000.00 USD | 2674933.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 28930.539% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 55188.101% |
| Altimmune, Inc. | -65.37 Million USD | 468.248% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 33.504% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 22514.804% |
| Compugen Ltd. | 31.45 Million USD | -665.331% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65358.209% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -881.951% |
| Benitec Biopharma Inc. | 108 Thousand USD | -222802.778% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 308734.615% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 20111.222% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 13312.678% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 202398.319% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 20111.222% |
| Instil Bio, Inc. | -4.75 Million USD | 5161.712% |
| argenx SE | 1.1 Billion USD | 78.282% |
| Immunome, Inc. | -8.9 Million USD | 2802.762% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 12837.302% |
| Verona Pharma plc | -679.62 Thousand USD | 35521.792% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 137662.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 10193.711% |
| CervoMed Inc. | -1.29 Million USD | 18709.305% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 10101.454% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 5139.46% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -9642.412% |
| Moolec Science SA | -143.3 Thousand USD | 168087.858% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 59099.338% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 9111.135% |
| AnaptysBio, Inc. | 14.78 Million USD | -1528.679% |
| Design Therapeutics, Inc. | -537 Thousand USD | 44929.609% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 56478.22% |
| NeurAxis, Inc. | 2.15 Million USD | -11062.172% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -11117.847% |
| Lumos Pharma, Inc. | 2 Million USD | -11894.768% |
| Achilles Therapeutics plc | -4.73 Million USD | 5188.172% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 137662.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 227906.955% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -660.406% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -27824.093% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 23427.035% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 628.53% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -559748.837% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 29386.496% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1829671.363% |
| Palisade Bio, Inc. | 246 Thousand USD | -97759.756% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 729600.0% |
| Beam Therapeutics Inc. | -59.67 Million USD | 503.43% |
| Neurogene Inc. | -3.26 Million USD | 7479.982% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -72.774% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6620.45% |
| Sesen Bio, Inc. | 40 Million USD | -501.838% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 81155.556% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 6077.968% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2616.569% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1609.766% |
| Athira Pharma, Inc. | -969 Thousand USD | 24943.653% |
| Vaccinex, Inc. | -16 Million USD | 1604.218% |
| HCW Biologics Inc. | -574.82 Thousand USD | 41979.775% |
| XOMA Corporation | 3.86 Million USD | -6135.043% |
| Nektar Therapeutics | 53.47 Million USD | -350.157% |
| Arvinas, Inc. | 71.8 Million USD | -235.286% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 388.44% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 483.489% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 74862.422% |
| Rezolute, Inc. | -36 Thousand USD | 668808.333% |
| Clene Inc. | 533 Thousand USD | -45066.041% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 18748931.776% |
| BeyondSpring Inc. | 1.75 Million USD | -13648.429% |
| Synlogic, Inc. | -1.92 Million USD | 12612.214% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 650735.135% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3901.879% |
| Peak Bio, Inc. | 367.76 Thousand USD | -65358.209% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1369.498% |
| Krystal Biotech, Inc. | 47.6 Million USD | -405.693% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -70.624% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4690.746% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 9397.591% |
| MannKind Corporation | 136.19 Million USD | -76.763% |
| Ikena Oncology, Inc. | -50.49 Million USD | 576.778% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -121.235% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5589.966% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 95629.762% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4814800.0% |
| Legend Biotech Corporation | 140.92 Million USD | -70.82% |
| Mural Oncology plc | -2.56 Million USD | 9478.068% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 43790.563% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 240835.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1059.945% |
| REGENXBIO Inc. | 53.02 Million USD | -353.969% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4593.879% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 125238.402% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 13999.249% |
| Vaxart, Inc. | -60.76 Million USD | 496.187% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 91710.853% |
| Cellectis S.A. | 18 Thousand USD | -1337316.667% |
| Longeveron Inc. | 221 Thousand USD | -108829.864% |
| Repare Therapeutics Inc. | -80.07 Million USD | 400.656% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 77.975% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 18703.941% |
| Revolution Medicines, Inc. | -399.66 Million USD | 160.234% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 687914.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -491195.918% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.203% |
| Denali Therapeutics Inc. | -93.34 Million USD | 357.898% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 961156.33% |
| Veru Inc. | 7.56 Million USD | -3081.83% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 159527.152% |
| Cingulate Inc. | -582.91 Thousand USD | 41398.262% |
| Passage Bio, Inc. | -3.72 Million USD | 6569.632% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1998896.081% |
| Exicure, Inc. | -1.42 Million USD | 17017.428% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 62955.091% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -8806.215% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 47056.649% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -253.367% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 161011.588% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 506.606% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -61469.054% |
| OmniAb, Inc. | 14.66 Million USD | -1541.338% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1104.096% |
| Lipocine Inc. | -2.85 Million USD | 8544.418% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 13162.127% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 4319.72% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 16081.972% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -219.633% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 370461.538% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -185.583% |
| Ocugen, Inc. | -33.53 Million USD | 817.819% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7713.378% |
| Q32 Bio Inc. | 578 Thousand USD | -41549.654% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 90943.396% |
| Alumis Inc. Common Stock | -1.28 Million USD | 18848.832% |
| Equillium, Inc. | 35.95 Million USD | -569.489% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 14202.812% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -47981.705% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5823394.63% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 93047.876% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -56850.122% |
| Dominari Holdings Inc. | 2.03 Million USD | -11706.523% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 131311.472% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1870.761% |
| Bio-Techne Corporation | 773.07 Million USD | 68.86% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1290.005% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 47.756% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 20693.242% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1103.899% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1958.092% |
| Nkarta, Inc. | -5.86 Million USD | 4201.806% |
| BioCardia, Inc. | -7.24 Million USD | 3420.941% |
| Iterum Therapeutics plc | -1.75 Million USD | 13856.286% |